Year |
Citation |
Score |
2024 |
Centner A, Del Priore I, Chambers N, Cohen SR, Terry ML, Coyle M, Glinski J, Stoll AC, Patterson JR, Kemp CJ, Miller KM, Kubik M, Kuhn N, Luk KC, Sortwell CE, et al. Deficits in basal and evoked striatal dopamine release following alpha-synuclein preformed fibril injection: An in vivo microdialysis study. The European Journal of Neuroscience. PMID 38356120 DOI: 10.1111/ejn.16275 |
0.541 |
|
2023 |
Budrow C, Elder K, Coyle M, Centner A, Lipari N, Cohen S, Glinski J, Kinzonzi N, Wheelis E, McManus G, Manfredsson F, Bishop C. Broad Serotonergic Actions of Vortioxetine as a Promising Avenue for the Treatment of L-DOPA-Induced Dyskinesia. Cells. 12. PMID 36980178 DOI: 10.3390/cells12060837 |
0.585 |
|
2022 |
Lipari N, Centner A, Glinski J, Cohen S, Manfredsson FP, Bishop C. Characterizing the relationship between L-DOPA-induced-dyskinesia and psychosis-like behaviors in a bilateral rat model of Parkinson's disease. Neurobiology of Disease. 105965. PMID 36526089 DOI: 10.1016/j.nbd.2022.105965 |
0.631 |
|
2022 |
Cohen SR, Terry ML, Coyle M, Wheelis E, Centner A, Smith S, Glinski J, Lipari N, Budrow C, Manfredsson FP, Bishop C. The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats. Pharmacology, Biochemistry, and Behavior. 217: 173393. PMID 35513119 DOI: 10.1016/j.pbb.2022.173393 |
0.625 |
|
2022 |
Cohen SR, Terry ML, Coyle, M, Wheelis E, Centner A, Smith S, Glinski J, Lipari N, Budrow C, Manfredsson FP, Bishop C. The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats Pharmacology, Biochemistry & Behavior. 217: 173393. PMID 35513119 DOI: 10.1016/j.pbb.2022.173393 |
0.496 |
|
2022 |
Smith S, Sergio J, Coyle M, Elder K, Centner A, Cohen S, Terry M, Lipari N, Glinski J, Wheelis E, Budrow C, Bishop C. The effects of Vilazodone, YL-0919 and Vortioxetine in hemiparkinsonian rats. Psychopharmacology. PMID 35275226 DOI: 10.1007/s00213-022-06078-9 |
0.638 |
|
Show low-probability matches. |